Date post: | 06-Mar-2015 |
Category: |
Documents |
Upload: | sudhendu007 |
View: | 319 times |
Download: | 4 times |
WELCOME TO
INDIAN PHARMACEUTIC
AL INDUSTRY
HISTORY CHARACTERISTIC FUTURE PROSPECTS POSITIONING DOMESTIC INDIAN PHARMA MARKET IMPORT & EXPORT INDIAN PHARMA MARKET TOP 10 PHARMA COMPANIES TOP 10 BRANDS FAST GROWING COMPANIES TOP 5 THERAPEUTIC SEGMENTS MERGER & AQUISITION
TOPICS
2006 2007 2008 2009
10.23
12.56
16.42
21.04
YEAR WISE TURN OVERVALUE IN BILLION US$
HISTORY
Highly fragmented with more than 20,000 registered units and 375 pharma companies.
Associated with severe price competition and government price control.
Presently growing at 8-9 % growth per annum
CHARACTERISTIC
Educated work force & english is frequently used
53 years old democracy and having solid framework & strong financial market.
International pharma industry finding great opportunities in INDIA.
Committed to free market economy & globalization.
WHY ONLY INDIA?
Year 2008-09:turn over is 21.04 billion US$. As per “INDIA PHARMA 2020” turn-over is
expected to reach 55 billion US$ in 2020. Domestic pharma-20 billion US$ Health care pharma- 31.59 billion US$ by
2020. So,india would really become a LUCRATIVE
destination for clinical trials.
FUTURE PROSPECTS
INDIAN PHARMACEUTICAL INDUSTRY is the 3rd largest in the world in terms of VOLUME.
INDIAN PHARMACEUTICAL INDUSTRY is on the 14th position in terms of VALUE.
POSITIONING
2007 2008 20090
2
4
6
8
10
12
14
16
18
20
SALES IN BILLION US$GROWTH IN %
DOMESTIC INDIAN MARKET
2003 2004 2005 2006 2007 2008 2009
SALES IN BIL-LION US$
2.57 3.04 3.57 4.45 5.38 6.15 7.69
GROWTH % NaN 18.61 17.38 24.41 21.06 14.37 24.94
2.5
12.5
22.5
EXPORT INDIAN PAHRMA MARKET
2003 2004 2005 2006 2007 2008 2009
0.57 0.590.63000000000
0001 0.9 1.17 1.35 1.714
7.02
42.07
30.14
15.18
26.87
SALES IN BILLION US$ GROWTH %
IMPORT INDIAN PHARMA MARKET
AS MARCH’2007
1. RANBAXY2. DR.REDDY’S LAB3. CIPLA4. SUN PHARMA5. LUPIN LTD6. AUROBINDO PHARMA7. GSK8. ZYDUS CADILA9. AVENTIS10. IPCA LAB
TOP 10 INDIAN PHARMA COMPANY
1. CIPLA2. RANBAXY3. DR.REDDY’S LAB4. SUN PHARMA5. LUPIN LTD6. AUROBINDO PHARMA7. PIRAMAL HEALTHCARE8. CADILA9. MATRIX10. WOCKHARDT
AS MARCH’2009
BRAND NAME CONTENT NAME OF COMPANY
COREX Chlorpheniramine,codeine sulphate
PFIZER
VOVERAN Diclofenac NOVARTIS
PHENSEDYL Chlorpheniramine, codeine sulphate.
PIRAMAL
HUMAN MIXTARD Insulin NOVO NORDISK
LIV-52 Ayurvedic product HIMALAYA
TAXIM Cefotaxime ALKEM
ZIFI Cefixime FDC
AUGMENTIN Amoxicillin,clavunic acid
GSK
MOX Amoxicillin RANBAXY
ASTHALIN salbutamol CIPLA
TOP 10 INDIAN PHARMA BRANDSAT SEPTEMBER 2009
BRAND NAME NAME OF COMPNAY
COMPOSITION INDICATION
LIPITOR PFIZER ATORVASTATIN HIGH CHOLESTEROL
PLAVIX SANOFI AVENTIS CLOPIDROGEL ATHEROSCLEROSIS
REMICADE MERCK & CO INFIXIMAB RHEUMATOID ARTHRITIS
ADVAIR GSK SALMETEROL FLUTICASONE
ASTHMA
ENBREL PFIZER ETANERCEPT JUVENILE IDIOPATHIC ARTHRITIS
TOP 5 GLOBAL BRANDS AT SEPTEMBER 2009
NAME OF THE COMPANY GROWTH RATE
MANKIND 37 %
SUN PHARMA 26 %
ABBOTT 25 %
ZYDUS 24 %
ALKEM 23.8 %
PFIZER 23.6%
FAST GROWING COMPANYAT SEPTEMBER 2009
SEGMENT 2006 2007 2008 2009
ANTI-INFECTIVE 43.7 49.7 56.9 64.3
GASTRO-INTESTINAL 27.1 30.5 34.1 38.9
CARDIO 25.3 28.2 30.3 36.5
PAIN/ANALGESIC 21.4 26.3 29.9 36.1
RESPIRATORY 22.9 25.8 28.4 34.6
TOP 5 THERAPEUTIC SEGMENTS
MERGER:is defined as voluntary amalgamation of two firms on roughly equal terms into one new legal entity.
ACQUISITION:The purchase of one corporation by another,through either the purchase of its shares or the purchase of its assets.
MERGER & AQUISITION
Effected by exchange of the pre-merger shares from the stock of the new firms.
To increase market shares,to gain access to promising new technologies,to achieve synergies in their operations.
To eliminate competition,reduce tax liabilities
But it is risky,because many things may go wrong with even a well laid plan to grow by AQUIRING.
REASONS FOR MERGERS & AQUISITION
PRE MERGER COMPANY
POST MERGER COMPANY
YEAR
ASTRA,ZENECA GROUP ASTRA ZENECA 1999
RHONE LTD AVENTIS 2000
GLAXO WELCOME-SMITHKLINE BEECHAM
GSK 2000
SANDOZ NOVARTIS 1996
PFIZER-LAMBERT PFIZER 2000
PFIZER-PHARMACIA PFIZER 2003
SANOFI-AVENTIS SANOFI AVENTIS 2004
LIST OF MERGER & AQUISITION
AQUIRED COMPANY AQUIRING COMPANY YEAR
RANBAXY DAICHI SANKYO 2008
WYETH PFIZER 2009
PIRAMAL HEALTHCARE ABBOTT 2010
PARAS RECKITT BENCKISER 2011
TEVA PHARMA SUN PHARMA 2011
LATEST AQUISITION